Work

Re: Sorafenib in Patients With Metastatic Renal Cell Carcinoma Refractory to Either Sunitinib or Bevacizumab

Year: 2011

Type: letter

Source: The Journal of Urology

DOI: 10.1016/s0022-5347(11)60174-2

Author: Samir S. Taneja

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2046752754

Cites:

Cited by:

Related to: 10